LESLEY LANTZ: Open Payments
NPI 1144295635 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 27 payments from 11 companies in 2025. Trend: 2023 $503 · 2024 $692 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $214 |
| Biogen, Inc. | 4 | $95 |
| Pharmacosmos Therapeutics Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
Products named: Veozah, ZURZUVAE, MONOFERRIC, SLYND, EVENITY, MYFEMBREE, APTIMA, Exparel.
Industry payments across IN — which companies pay providers there.
